The global Lennox-Gastaut syndrome therapeutics market is undergoing a period of significant growth. This phenomenon can be credited to several factors, including an growing prevalence of Lennox-Gastaut syndrome globally and developments in treatment options. The market is stimulated by a growing demand for effective therapies to treat the complex